Search

Your search keyword '"Jae-Yong Ahn"' showing total 11 results
Start Over "Jae-Yong Ahn" Publication Year Range Last 10 years Database Gale General OneFile
11 results on '"Jae-Yong Ahn"'

1. New Alzheimer Disease Study Findings Recently Were Published by Researchers at Konkuk University (AD-1 Small Molecule Improves Learning and Memory Function in Scopolamine-Induced Amnesic Mice Model through Regulation of CREB/BDNF and NF-kB/MAPK ...)

Subjects
Alzheimer's disease -- Drug therapy -- Models -- Complications and side effects, Cognition disorders -- Models -- Risk factors -- Drug therapy, Transcription factors -- Physiological aspects -- Health aspects, Brain-derived neurotrophic factor -- Physiological aspects -- Health aspects, Health
Abstract

2023 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Alzheimer disease is the subject of a new report. [...]

Published
2023

2. SK bioscience, GSK submit BLA for adjuvanted Covid-19 vaccine candidate, SKYCovione with Korean Ministry of Food and Drug Safety

Subjects
AstraZeneca PLC, Food -- Safety and security measures, Health care industry, Vaccines, Recombinant proteins, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

SK bioscience, an innovative biopharmaceutical company, and GSK, a science-led global healthcare company, announced submission of a biologics license application (BLA) for SKYCovione a recombinant protein-based Covid-19 vaccine candidate adjuvanted [...]

Published
2022

3. New Findings from Konkuk University in the Area of Alzheimer Disease Reported (Ad-1 Small Molecule Improves Learning and Memory Function In Scopolamine-induced Amnesic Mice Model Through Regulation of Creb/bdnf and Nf-kappa B/mapk Signaling ...)

Subjects
Brain damage -- Research, Medical research -- Reports, Medicine, Experimental -- Reports, Advertising executives -- Reports -- Research, Alzheimer's disease -- Research, Scopolamine -- Research, Health
Abstract

2023 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Neurodegenerative Diseases and Conditions - Alzheimer Disease is now [...]

Published
2023

4. United Kingdom,United States : SK bioscience and GSKs adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione(GBP510|GSK adjuvant) in South Korea

Subjects
Food -- Safety and security measures, Vaccines -- Licensing agreements, Recombinant proteins, Company licensing agreement, Business, international
Abstract

Recombinant protein-based GBP510 with GSK pandemic adjuvant demonstrates superior neutralising titres compared to a control vaccine and clinically favourable safety profile SK submits license application to MFDS to support vaccine [...]

Published
2022

5. SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione(GBP510/GSK adjuvant) in South Korea

Subjects
South Korea
Abstract

ENPNewswire-May 2, 2022--SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione(GBP510/GSK adjuvant) in South Korea (C)2022 ENPublishing [...]

Published
2022

6. SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione™(GBP510/GSK adjuvant) in South Korea

Subjects
Vaccines, Recombinant proteins, Business, Business, international
Abstract

M2 PRESSWIRE-April 29, 2022-: SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione™(GBP510/GSK adjuvant) in South Korea [...]

Published
2022

7. LATEST COMPANY NEWS

Subjects
United States. Food and Drug Administration, United States. Supreme Court, Pfizer Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, Antiviral agents -- Health aspects, Infection -- Health aspects, Coronaviruses -- Health aspects, Pharmaceutical industry -- Health aspects, Business, international, European Union, Olumiant (Medication) -- Health aspects, Jardiance (Medication) -- Health aspects, Forteo (Medication) -- Health aspects, Ultomiris (Medication) -- Health aspects, Retevmo (Medication) -- Health aspects, Paxlovid (Medication) -- Health aspects, Advair Diskus (Medication) -- Health aspects
Abstract

Labmate Online - Building begins on Cannabis-based Medicines Facility in UK - 30/4/2022 The recent initiation of construction of its new 60,000 sq ft manufacturing facility at Kent Science Park [...]

Published
2022

8. CEPI funds Phase 3 trial of UW Medicine COVID-19 vaccine

Subjects
Medical research, Medicine, Experimental, Clinical trials, Vaccines, Coronaviruses, Industrial research -- South Korea, Research and development, Business, international, Law, Coalition for Epidemic Preparedness Innovations
Abstract

A COVID-19 nanoparticle vaccine candidate, named GPB510, has received significant additional funding from the Coalition for Epidemic Preparedness Innovations (CEPI). The funding, which will go to SK bioscience, will enable [...]

Published
2021

9. Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Subjects
Clinical trials -- Analysis, Vaccines -- Product development, Typhoid fever -- Analysis, Business, international, Law
Abstract

Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal. The primary endpoints [...]

Published
2020

10. IVI-SK's new typhoid conjugate vaccine meets primary endpoints in phase III study in Nepal

Subjects
Clinical trials -- Analysis, Vaccines -- Product development, Typhoid fever -- Analysis, Health, World Health Organization
Abstract

2020 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- SEOUL, South Korea - Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute [...]

Published
2020

11. RUSNANO'S PORTFOLIO COMPANY 'NANOLEK' AND SOUTH KOREAN SK CHEMICALS ARE LAUNCHING A JOINT PROJECT FOR THE DEVELOPMENT AND PRODUCTION OF VACCINES

Subjects
Vaccines -- Planning, Investment companies -- Planning, Medical research, Company business planning, News, opinion and commentary
Abstract

MOSCOW, Russia -- The following information was released by the Russian Corporation of Nanotechnologies (RUSNANO): NANOLEK announces cooperation in joint developments, research and production of vaccines with SK Chemicals, one [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results